| 482.09 -1.23 (-0.25%) | 09-18 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 579.53 | 1-year : | 676.9 |
| Resists | First : | 496.17 | Second : | 579.53 |
| Pivot price | 484.72  |
|||
| Supports | First : | 477.56 |
Second : | 466.05 |
| MAs | MA(5) : | 488.13 |
MA(20) : | 484.84 |
| MA(100) : | 437.62 |
MA(250) : | 379.45 |
|
| MACD | MACD : | 5.6 |
Signal : | 7 |
| %K %D | K(14,3) : | 64.8 |
D(3) : | 75.2 |
| RSI | RSI(14): 52.7 |
|||
| 52-week | High : | 496.17 | Low : | 254.85 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ ISRG ] has closed above bottom band by 39.1%. Bollinger Bands are 27.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 489.33 - 492.39 | 492.39 - 494.55 |
| Low: | 472.28 - 476.12 | 476.12 - 478.83 |
| Close: | 477.06 - 482.67 | 482.67 - 486.62 |
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Wed, 18 Sep 2024
Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views? - Yahoo Finance
Wed, 18 Sep 2024
Intuitive Surgical, Inc. (ISRG): A Bear Case Theory - Insider Monkey
Tue, 17 Sep 2024
Intuitive Surgical, Inc. (ISRG) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Mon, 16 Sep 2024
Insider Sale: Director Amy Ladd Sells Shares of Intuitive Surgical Inc (ISRG) - GuruFocus.com
Mon, 16 Sep 2024
What You Can Learn From Intuitive Surgical, Inc.'s (NASDAQ:ISRG) P/S - Simply Wall St
Thu, 12 Sep 2024
Intuitive Surgical, Inc. (ISRG): A Very Important AI Stock According to BlackRock - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 355 (M) |
| Shares Float | 353 (M) |
| Held by Insiders | 0.5 (%) |
| Held by Institutions | 90.6 (%) |
| Shares Short | 3,940 (K) |
| Shares Short P.Month | 3,390 (K) |
| EPS | 5.82 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 41.4 |
| Profit Margin | 27.6 % |
| Operating Margin | 28.2 % |
| Return on Assets (ttm) | 7.9 % |
| Return on Equity (ttm) | 15.7 % |
| Qtrly Rev. Growth | 14.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 21.3 |
| EBITDA (p.s.) | 6.72 |
| Qtrly Earnings Growth | 23.7 % |
| Operating Cash Flow | 1,660 (M) |
| Levered Free Cash Flow | 372 (M) |
| PE Ratio | 82.69 |
| PEG Ratio | 5.2 |
| Price to Book value | 11.64 |
| Price to Sales | 22.63 |
| Price to Cash Flow | 103.19 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|